KNIGHT CAPITOL CONSULTANTS for INDIVIOR, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
Adequacy of funding for state-based efforts to provide treatment for substance use disorders
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch |
Budget/Appropriations BUD
Funding for mental health and substance abuse research and grants; issues related to provisions affecting regulation and pricing of pharmaceuticals in the Build Back Better Act (H.R. 5376).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch |
Medicare/Medicaid MMM
The Medicaid Re-entry Act (H.R. 955/S. 445); policies related to reimbursement of substance use disorder treatment (no specific legislation). Possible changes in reimbursement for pharmaceuticals (HR 3, HR 5376 - Build Back Better Act, and any successor legislation)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch (1999-2007) |
Health Issues HCR
Implementation of section 3204 of the SUPPORT Act, PL 115-271; Mainstreaming Addiction Treatment Act (HR 2067); Medication Access and Training Expansion Act; (S 5000). Drug Enforcement Administration regulation of buprenorphine under the Controlled Substances Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.